1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
3 |
| Hold |
2 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Sep 2025 | |
|---|---|---|
| Revenue | 0.00 | - |
| Gross profit | −306.77k | - |
| Net profit | −23.93m | - |
| EBITDA | −26.27m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 5.79k€ |
Number of shares | 33.71m |
52-week high/low | 0,16€ - 0,0000859€ |
| Dividends | No |
Beta | 1,62 |
P/E ratio | 0,00 |
PEG ratio | 0,00 |
P/B ratio | 0,00 |
P/S ratio | 0,00 |
Company profile
| Name | Windtree Therapeutics Aktie |
| CEO | Jed A. Latkin |
| Employees | 14 |
Discover assets
Shareholders of Windtree Therapeutics Aktie also invest in the following assets
